The role of the intradiscal polypeptide loops in bovine rhodopsin has been investigated by deletions in the N-terminal tail and in loops B-C, D-E, and E-F as well as by single amino acid substitutions in the D-E loop. Mutants with three types of phenotypes were observed. Type I mutants showed a rhodopsin-like chromophore and glycosylation. Type II mutants did not regenerate the chromophore and showed abnormal glycosylation. Type mI mutants showed poor chromophore regeneration and abnormal glycosylation. Reduced transducin activation was shown by some type I and Ill mutants. Single amino acid substitutions in the D-E loop gave mostly type I mutants. Deletions in loops B-C, D-E, and F-G gave type II mutants, whereas deletions in the N-terminal tail produced type HI mutants. Systematic deletions of two adjacent amino acids in loop D-E indicated that the amino acid sequences 171-182 and 189-192 were essential to rhodopsin structure. Immunofluorescence double-staining and transmission electron microscopy of one type II mutant (with residues 189 and 190 deleted) showed that it was mostly in the endoplasmic reticulum, whereas the wild-type protein was in the plasma membrane. We conclude that the first step in the assembly of the rhodopsin molecule is the formation of a three-dimensional structure in the intradiscal domain involving the bulk of the out-of-the-membrane polypeptide segments followed by the linkage of Cys-110 and Cys-187 through a disulfide bond.
Rhodopsin, the photoreceptor in the vertebrate rod cells (1) , consists of a single polypeptide chain of 348 amino acids. It is believed to contain seven transmembrane helical segments (2) (Fig. 1) , with roughly half of the protein embedded in the membrane and the other half distributed between the cytoplasmic and intradiscal domains, which contain peptide loops of various sizes and the N-and C-terminal tails. Light activation of rhodopsin prepares the molecule for interaction with transducin, the GTP-binding regulatory protein, and allows its phosphorylation by rhodopsin kinase and subsequent interaction with the 48-kDa protein, S antigen (3) . These interactions all occur on the cytoplasmic face of rhodopsin. In contrast, the role of the intradiscal domain in rhodopsin structure and/or function has remained unclear. Recently, systematic replacements of cysteine residues in rhodopsin were carried out (4) . This study showed that the intradiscal Cys-110 and Cys-187 ( Fig. 1) are essential for the formation of functional rhodopsin and that these two cysteines form a disulfide bond between them. To clarify further the role of the intradiscal domain in rhodopsin function, we have now performed deletion mutagenesis in the N-terminal tail and the three intradiscal loops as well as single amino acid substitutions in loop D-E (Fig. 1) . The results show that relatively short deletions in any one of the loops or in the N-terminal tail affect the assembly of functional rhodopsin.
We conclude that the role of the intradiscal domain in rhodopsin is structural. Very likely this comprises the formation of a folded structure from the bulk of the intradiscal polypeptide segments, a structure that is stabilized by the disulfide bond between Cys-110 and Cys-187. The intradiscal structure leads to the correct alignment of the membraneembedded helices and, consequently, the correct structure at the cytoplasmic surface.
MATERIALS AND METHODS Materials. Oligonucleotides were synthesized and characterized as described (5) . Dodecyl maltoside was purchased from Sigma and was further purified (6 (11) . Mutants A4 and 10 ( Fig. 1 ) have one additional amino acid, histidine and serine, respectively, in addition to the deletions as a result of blunt-end ligation of Fsp I and Sca I sites or ligation of Xba I and Sph I sites with one oligonucleotide. The DNA sequences around the replaced oligonucleotides were confirmed by the chain-termination method (12) .
Expression and Purification of Rhodopsin Mutants. The wild-type synthetic rhodopsin gene and mutant genes were expressed in COS-1 cells as described (7) , and the cells were harvested 3 days after transfection. For mutants that showed normal glycosylation, the transfected cells were incubated with 11-cis-retinal (2-10 ,uM) and solubilized in 1% (wt/vol) dodecyl maltoside, and the proteins were purified by immunoaffinity chromatography in 0.1% or 0.2% dodecyl malto- side as described (4) . The regenerated pigments showed A280/A495 ratios in the range of 1.7-3.0. For mutants that showed abnormal glycosylation, incubation with 11-cis-retinal was performed after homogenization of transfected cells or by using the postnuclear supernatants of disrupted cells to ensure the accessibility of 11-cis-retinal to all the membranes. Disruption of cells was followed by phase-contrast microscopy. For mutants A14, A1-A4, and Asp-190--Ala (D190A), after absorption of the protein to immunoaffinity matrix, washes and elution were carried out in the presence of 0.075% (wt/vol) egg phosphatidylcholine (Avanti Polar Lipids), 0.05% (wt/vol) 3-[(3-cholamidopropyl)dimethylammoniol-1-propane sulfonate (CHAPS), and 0.1% (wt/vol) dodecyl maltoside to increase the stability of the solubilized proteins. The purified proteins were characterized by UV/ visible spectroscopy and by NaDodSO4/polyacrylamide gel electrophoresis followed by immunoblotting with rho 1D4, a mouse monoclonal antibody specific for the C terminus of rhodopsin. An extinction coefficient of42,700 M-1 cm-1 at495 nm (13) was used for rhodopsin. Photobleaching of the chromophore was performed with a Fiber-Lite A-200 (DolanJenner Industries) light source equipped with a cut-off glass filter of 495 nm.
Transducin Activation Assay. Purified rhodopsin mutants were assayed for their ability to activate transducin by (i) the GTPase activity and (ii) the exchange of the bound GDP for the nonhydrolyzable GTP analogue GTP[y-35S]. The rhodopsin mutants were diluted to 5-100 nM in a solution containing 50 mM Tris-HCI, pH 6.8/0.1 M NaCl/1 mM CaC12/0.07% egg phosphatidylcholine/0.05% CHAPS/0.1% dodecyl maltoside at room temperature. Inclusion of phosphatidylcholine enhanced the activation of transducin by 2-to 3-fold, but preincubation with rhodopsin for about 30 min was required for optimal results. The final concentrations of phosphatidylcholine, CHAPS, and dodecyl maltoside in the reaction mixture of both assays were 0.0075%, 0.005%, and 0.01%, respectively (10) .
The concentration of rhodopsin mutants used in the GTPase assay (4) was 2.5 nM, which is within the linear range of the assay. The concentrations of transducin and [y-32P]GTP were 3.6 ,uM and 10-11 ,AM, respectively.
The GTP[y-35S] exchange assay by filter binding was carried out basically as described (14) . The initial velocities of the exchange reaction were measured for various transducin concentrations (0.5, 0.9, 1.45, and 2.5 ;LM) at 5-7 jiM GTP[y-35S].
The recovery of transducin bound to the nitrocellulose filters was not included in calculations. The apparent Km and Vmax were obtained by plotting (initial velocities)-' as a function of
[transducin]f2: a linear relation was obtained (14) .
Immunofluorescent Double-Staining of COS-1 Cells. COS-1 cells were grown on glass slips in plates, transfected as described, and further cultured for 67 hr. Cells were fixed and permealized in methanol for 5 min at -20'C and in acetone for 5 min at -200C, then dried and rehydrated in phosphatebuffered saline (10 mM sodium phosphate buffer, pH 7/150 mM NaCI2/0.02% NaN3). The fixed cells were incubated with mouse monoclonal antibody rho 1D4 (10 ;Lg/ml) followed by staining with rhodamine-conjugated goat antimouse IgG (10 jig/ml). Cells were further incubated with rabbit polyclonal antibody for endoplasmic reticulum resident proteins (15) and then washed and stained with fluorescein-conjugated goat anti-rabbit IgG. Finally, the cells were washed with phosphate-buffered saline and mounted on glass microscope slides.
Immunogold-Dextran Labeling of COS-1 Cells. Transfected COS-1 cells were fixed in 1.25% glutaraldehyde/phosphatebuffered saline, indirectly labeled with the N-terminalspecific rhodopsin monoclonal antibody rho 4D2 and protein A-gold-dextran conjugates, and processed for transmission electron microscopy as described (7) . Hybridoma cell culture fluid containing the rho 4D2 antibody was diluted 1:10 in phosphate-buffered saline for the first labeling step. Stock protein A-gold-dextran conjugate having an approximate diameter of 10 nm and an A520 of 10 was diluted 1:20 for the second labeling step.
RESULTS
The total deletions and single amino acid substitutions made are shown in Fig. 1 . The expression levels of all the mutants were comparable to that of the wild-type proteins. The mutants could be divided into three types (Table 1) as described below.
Type I: Mutants Whose Phenotype Resembles That of the Wild-Type Opsin. These included the two-amino-aciddeletion mutants A18, A19, A21, A22, and A23, one fouramino-acid-deletion mutant, A20, and the substitution mutants Y191L, Y192L, T193V, P194A, and P194G. These mutations, which are all located in loop D-E near helix E, generated the typical rhodopsin chromophore (Amax = 495 nm) ( Fig. 2A) . However, while the wild-type and most of the type I mutant chromophores shifted quantitatively to 380 nm ( Fig. 2A) on irradiation for 10 + 10 sec, the mutants A18, Y191L, and Y192L showed distinctly different photobleached spectra (Fig. 2B) .
The glycosylation pattern of type I mutants in COS-1 cells is exemplified by the immunoblotting of the cell lysate containing mutant A18 proteins (Fig. 3A) . The protein pattern showed an unglycosylated band (31 kDa), the major glycosylated band (41 kDa), and a series of protein bands with successively decreasing mobility from 41 kDa to 68 kDa. This is very similar to the wild-type glycosylation pattern (Fig. 3A) .
The above type I mutants, which regenerated the chromophore, were studied for their ability to activate transducin. Kinetics of typical GTPase activity are shown in Fig. 4 . Type II: Mutants That Fail to Generate Rhodopsin Chromophore and Cause Abnormal Glycosylation. These mutations comprised relatively large deletions (A5 in loop B-C; A10, A13, and A16 in loop D-E; and A27 in loop F-G as well as twoamino-acid deletions, A6-A9, All-A12, A15, A17, and A24-A26 in loop D-E) ( Table 1) . None ofthese mutants regenerated rhodopsin-like chromophore when, after expression in COS-1 cells, the membranes were incubated with 11-cis-retinal, as shown, for example, for mutant A15 (Fig. 2C) .
The mutants showed a markedly different glycosylation pattern [e.g., mutant A15 (Fig. 3A) ]. Thus, three major protein bands of 31, 36, and 41 kDa were observed, and the minor bands (smear) between 41 and 68 kDa characteristic of the wild-type proteins were absent. The difference in the glycosylation pattern between the wild-type and type II mutants is further shown in Fig. 3B by prised deletions in the N-terminal tail (A1-A4), A14 with a two-amino-acid deletion in loop D-E, and a single amino acid substitution (D19OA) mutant (Fig. 1) . After purification, the above mutants generated the rhodopsin chromophore only to the extent of 10-20% of the wild type, as shown for A3 in Fig.   2D The glycosylation pattern exemplified in Fig. 3A for mutant A&3 was typical for these mutants: it was different from those of type I and type II mutants. Thus, while the major bands, 41 and 31 kDa, were present, the bands between 41 and 68 kDa, characteristic of normal opsin glycosylation in COS-1 cells, and the 36-kDa band were all minor or absent. Also, type III mutants, like type II mutants, tended to form dimers and trimers.
In GTPase assay, deletion mutants of the N-terminal tail and A14 showed 10-20o of the wild-type initial rate, and the activity decayed quickly. However, the mutant D190A showed wild-type kinetics. In the GDP-GTP[y-S] exchange assay, mutant A3 (Fig. 1) did not show any detectable activity (data not shown).
Localization of the Type II Mutant, A15, in COS-1 Cells. The sensitivity of the carbohydrates of type II mutant proteins to endo H indicated that these proteins were not transported from the endoplasmic reticulum to the Golgi for processing of the high-mannose carbohydrate. Therefore, localization of the type II mutant A15 in COS-1 cells was studied, as an example, by indirect immunofluorescence double-staining (Fig. 5) and transmission electron microscopy (Fig. 6) .
For immunofluorescence labeling, permealized COS-1 cells were stained with rhodamine for opsin proteins and fluorescein for endoplasmic reticulum proteins. The cells expressing the wild-type proteins showed different distributions of the two types of fluorescence. Thus, rhodamine stained the whole region and the edge of the cells (Fig. 5B) , while fluorescein stained the region around the nuclei (Fig.  5C ). In contrast, in cells expressing the mutant A15, rhodamine and fluorescein stained similar regions of the cells around the nuclei (Fig. 5 D-F) , indicating the location of S15 protein around the endoplasmic reticulum.
COS-1 cells transfected with the wild-type, A15 (type II), or A18 (type I) plasmids were also labeled with the Nterminal-specific rho 4D2 rhodopsin monoclonal antibody and protein A-gold conjugates. As visualized by transmission electron microscopy, COS-1 cells expressing the wild-type protein (Fig. 6 Top) and A18 mutant (Fig. 6 Bottom) showed dense gold labeling of the plasma membrane, whereas most of the cells transfected with the A15 plasmid showed sparse labeling at the cell surface (Fig. 6 Middle) . Since Immunogold-dextran particles conjugated to goat anti-mouse antibody followed the labeling by monoclonal mouse antibody 4D2 for rhodopsin. A... 3 ). This class of mutations comprised relatively large deletions (A5, A10, and A27) and two-amino-acid deletions between positions 171 and 192 ( Fig. 1 ) and between positions 203 and 208 (Table 1 and Fig. 1 ). Type III mutations were also defective in that they regenerated the chromophore very poorly and their glycosylation pattern was different from those of type I and type II mutants. Type III mutants represented deletions in the N-terminal tail (Table 1) , the two-amino-acid deletion A14, and the amino acid substitution D19OA. One type II mutant, A15, was examined for its cellular location in COS-1 cells, the system used for expression of all of the mutants. The mutant protein was located mostly in the endoplasmic reticulum and not in the plasma membrane where the wild-type rhodopsin was present (Fig. 6) . We believe that all the defective proteins, like A15, remain in the endoplasmic reticulum, as is the case for such proteins in general (18) (19) (20) (21) .
The fact that defective rhodopsin structures of type II and type III can arise by single relatively short deletions in any one of the loops, B-C, D-E, or F-G, or the N-terminal tail (Table 1) suggests that these segments are all cooperatively involved in forming a specific folded structure on the intradiscal face. We believe that this structure is stabilized by the disulfide bond (S. Karnik and H.G.K., unpublished work) between Cys-110 and Cys-187. The deletions now described produce defective opsins because they do not allow the formation of the specific tertiary structure. Recently, rhodopsin in one form of retinitis pigmentosa has been shown to carry the point mutation P23H (22) . We hypothesize that this mutation also does not allow the formation of the above intradiscal structure.
We have also carried out a large number of deletion and point mutations in loops C-D and E-F on the cytoplasmic face (R. Franke, T. Sakmar, and H.G.K., unpublished work). In contrast with the deletion mutations in the intradiscal face, mutations in the cytoplasmic loops do not affect regeneration of the rhodopsin chromophore. We propose that the mode of assembly and functions of the cytoplasmic and intradiscal domains are very different. The function of the intradiscal domain is structural, while the cytoplasmic face carries out the biochemical and regulatory functions. In summary, we postulate the following main steps in the assembly and function of rhodopsin: (i) separate and uncoordinated insertion of the seven helical segments into the membrane in endoplasmic reticulum and glycosylation to form mannoserich oligosaccharides, (ii) formation of the intradiscal tertiary structure including the Cys-110 and Cys-187 disulfide bond followed by alignment and formation of the seven-helix bundle in the membrane, (iii) transport to the Golgi and processing of glycosylation and palmitoylation, and (iv) migration to the plasma membrane and addition of the 11-cisretinal.
Light transduction initiated by cis -+ trans-retinal isomerization will cause perturbation of the helices, the effect will be transmitted specifically to the cytoplasmic face, and the new "open" structures formed will allow the interaction of transducin and other proteins with the "activated" rhodopsin.
A large number of transmembrane receptors that couple to GTP-binding regulatory proteins contain disulfide bonds equivalent to the intradiscal disulfide bond in rhodopsin (23) . Deletions in the loops involving the disulfide bond result in decreased affinity for the ligand binding and in the abnormal glycosylation of the receptors (24) . The structural evidence on this superfamily of receptors suggests a common principle for their architecture and function as we have now proposed for rhodopsin.
